Public endorsements by prominent investors like Josh Brown can lead to increased investor confidence and potentially drive up the stock price of the company in question. Given Brown's visibility and influence, his decision to buy more Pfizer shares could be seen as a strong vote of confidence in the company's future prospects, likely leading to a positive short-term impact on Pfizer's stock price.